Drugs and Devices

U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase)

On Jan. 17, the U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase) to treat patients with toxic blood levels of methotrexate because of renal failure. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares